CAS:171887-03-9|N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide

CAS:171887-03-9|N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide

Catalogue Number:A604735
Chemical Name:N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide
Synonyms:N-(2-Amino-4,6-dichloropyrimidin-5-yl)formamide; Abacavir – In House Impurity; Abacavir Impurities
Impurity:Abacavir – In House Impurity:CAS Number:171887-03-9
Molecular Formula:C₅H₄Cl₂N₄O
Appearance:Off-White to Pale Beige Solid
Melting Point:>251°C (dec.)
Molecular Weight:207.02
Storage:4°C, Inert atmosphere, Light sensitive
Solubility:DMSO, Methanol
Category:Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide (Abacavir – In House Impurity) is an intermediate of Abacavir (A105000). Abacavir is a carbocyclic 2′-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug used to treat HIV infection (1). Intracellular enzymes convert Abacavir to its active form, carbovir-triphosphate (CBV-TP), which then selectively inhibits HIV reverse transcriptase by incorporating into viral DNA (2). Abacavir is metabolized in the liver by uridine diphosphate glucuronyltransferase and alcohol dehydrogenase resulting in inactive glucuronide and carboxylate metabolites, respectively.
References:(1) Jackson, A., et al.: Antivir Ther. 17, 19 (2012)
(2) Yuen, G. J., et al.: Clin Pharmacokinet. 47, 351 (2008)
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *